

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories. Among its major competitors, Tetraphase Pharmaceuticals is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $15.98M